News
Drug for heart failure increases mortality
BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7498.981-a (Published 28 April 2005) Cite this as: BMJ 2005;330:981- David Spurgeon
- Quebec
Patients with heart failure who were treated with the drug nesiritide to help them survive a crisis were 80% more likely to die in the month after treatment than were patients who had received traditional drugs for symptoms of acute heart failure. This was the finding of a US study published last week in JAMA (2005;293: 1900-5).
The drug's manufacturer Scios, which is part of Johnson & Johnson, released …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.